Product Code: ETC4746675 | Publication Date: Nov 2023 | Updated Date: Apr 2025 | Product Type: Market Research Report | |
Publisher: 6Wresearch | Author: Sachin Kumar Rai | No. of Pages: 60 | No. of Figures: 30 | No. of Tables: 5 |
The Greece Influenza Vaccine Market is projected to witness mixed growth rate patterns during 2025 to 2029. The growth rate starts at 1.76% in 2025 and reaches 3.01% by 2029.
Greece's Influenza Vaccine market is anticipated to experience a stable growth rate of 1.12% by 2027, reflecting trends observed in the largest economy Germany, followed by United Kingdom, France, Italy and Russia.
The influenza vaccine market in Greece is expanding due to increasing awareness about the importance of vaccination and rising seasonal flu outbreaks. The Greek government, in collaboration with public health organizations, promotes vaccination programs to protect the population, especially the elderly and vulnerable groups. The market is further supported by the availability of new and improved vaccines that offer enhanced protection against different strains of the flu virus. As healthcare access improves, the demand for influenza vaccines is expected to rise in the coming years.
The influenza vaccine market in Greece is shaped by rising awareness about seasonal flu prevention and government vaccination programs. The growing elderly population and initiatives to increase immunization rates contribute to the market`s steady growth.
The influenza vaccine market in Greece faces challenges related to public hesitancy and skepticism about vaccine safety. There is also the issue of maintaining a cold chain for the storage and distribution of vaccines, particularly in remote areas. Another challenge is government funding and policies that affect the affordability and accessibility of vaccines, impacting overall vaccination rates.
Greece has a robust public health policy supporting the influenza vaccine market, particularly with respect to universal vaccination programs. The government works alongside the European Union to ensure the availability and accessibility of vaccines through national immunization programs. Public awareness campaigns about the benefits of flu vaccination, especially for vulnerable populations, are regularly promoted. Greece`s health ministry also collaborates with international organizations to ensure the timely procurement and distribution of vaccines during flu seasons.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Greece Influenza Vaccine Market Overview |
3.1 Greece Country Macro Economic Indicators |
3.2 Greece Influenza Vaccine Market Revenues & Volume, 2021 & 2031F |
3.3 Greece Influenza Vaccine Market - Industry Life Cycle |
3.4 Greece Influenza Vaccine Market - Porter's Five Forces |
3.5 Greece Influenza Vaccine Market Revenues & Volume Share, By Vaccine type, 2021 & 2031F |
3.6 Greece Influenza Vaccine Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.7 Greece Influenza Vaccine Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.8 Greece Influenza Vaccine Market Revenues & Volume Share, By Age Group, 2021 & 2031F |
3.9 Greece Influenza Vaccine Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
4 Greece Influenza Vaccine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Greece Influenza Vaccine Market Trends |
6 Greece Influenza Vaccine Market Segmentations |
6.1 Greece Influenza Vaccine Market, By Vaccine type |
6.1.1 Overview and Analysis |
6.1.2 Greece Influenza Vaccine Market Revenues & Volume, By Quadrivalent, 2021-2031F |
6.1.3 Greece Influenza Vaccine Market Revenues & Volume, By Trivalent, 2021-2031F |
6.2 Greece Influenza Vaccine Market, By Type |
6.2.1 Overview and Analysis |
6.2.2 Greece Influenza Vaccine Market Revenues & Volume, By Seasonal, 2021-2031F |
6.2.3 Greece Influenza Vaccine Market Revenues & Volume, By Pandemic, 2021-2031F |
6.3 Greece Influenza Vaccine Market, By Technology |
6.3.1 Overview and Analysis |
6.3.2 Greece Influenza Vaccine Market Revenues & Volume, By Egg-based, 2021-2031F |
6.3.3 Greece Influenza Vaccine Market Revenues & Volume, By Cell-based, 2021-2031F |
6.4 Greece Influenza Vaccine Market, By Age Group |
6.4.1 Overview and Analysis |
6.4.2 Greece Influenza Vaccine Market Revenues & Volume, By Pediatric, 2021-2031F |
6.4.3 Greece Influenza Vaccine Market Revenues & Volume, By Adult, 2021-2031F |
6.5 Greece Influenza Vaccine Market, By Route of Administration |
6.5.1 Overview and Analysis |
6.5.2 Greece Influenza Vaccine Market Revenues & Volume, By Injection, 2021-2031F |
6.5.3 Greece Influenza Vaccine Market Revenues & Volume, By Nasal Spray, 2021-2031F |
7 Greece Influenza Vaccine Market Import-Export Trade Statistics |
7.1 Greece Influenza Vaccine Market Export to Major Countries |
7.2 Greece Influenza Vaccine Market Imports from Major Countries |
8 Greece Influenza Vaccine Market Key Performance Indicators |
9 Greece Influenza Vaccine Market - Opportunity Assessment |
9.1 Greece Influenza Vaccine Market Opportunity Assessment, By Vaccine type, 2021 & 2031F |
9.2 Greece Influenza Vaccine Market Opportunity Assessment, By Type, 2021 & 2031F |
9.3 Greece Influenza Vaccine Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.4 Greece Influenza Vaccine Market Opportunity Assessment, By Age Group, 2021 & 2031F |
9.5 Greece Influenza Vaccine Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
10 Greece Influenza Vaccine Market - Competitive Landscape |
10.1 Greece Influenza Vaccine Market Revenue Share, By Companies, 2024 |
10.2 Greece Influenza Vaccine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations | 13 Disclaimer |